238 related articles for article (PubMed ID: 17848300)
1. Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
Chung CH; Wong S; Ang KK; Hammond EH; Dicker AP; Harari PM; Le QT
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S67-78. PubMed ID: 17848300
[TBL] [Abstract][Full Text] [Related]
2. Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.
Psyrri A; Licitra L; Lacombe D; Schuuring E; Budach W; Ozsahin M; Knecht R; Vermorken JB; Langendijk JA
Ann Oncol; 2010 Oct; 21(10):1952-1960. PubMed ID: 20305037
[TBL] [Abstract][Full Text] [Related]
3. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.
Glazer CA; Chang SS; Ha PK; Califano JA
Oral Oncol; 2009; 45(4-5):440-6. PubMed ID: 18674958
[TBL] [Abstract][Full Text] [Related]
4. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma: new translational therapies.
Prince A; Aguirre-Ghizo J; Genden E; Posner M; Sikora A
Mt Sinai J Med; 2010; 77(6):684-99. PubMed ID: 21105129
[TBL] [Abstract][Full Text] [Related]
6. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Marur S; Forastiere AA
Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
[TBL] [Abstract][Full Text] [Related]
7. Is gene expression profiling of head and neck cancers ready for the clinic?
Ziober AF; D'Alessandro L; Ziober BL
Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
[TBL] [Abstract][Full Text] [Related]
8. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
9. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Lassen P
Radiother Oncol; 2010 Jun; 95(3):371-80. PubMed ID: 20493569
[TBL] [Abstract][Full Text] [Related]
10. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial design limitations in head and neck squamous cell carcinomas.
Yun HJ; Bogaerts J; Awada A; Lacombe D
Curr Opin Oncol; 2007 May; 19(3):210-5. PubMed ID: 17414638
[TBL] [Abstract][Full Text] [Related]
12. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Sacco AG; Cohen EE
J Clin Oncol; 2015 Oct; 33(29):3305-13. PubMed ID: 26351341
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in squamous cell carcinoma of the head and neck.
Gold KA; Lee HY; Kim ES
Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
[TBL] [Abstract][Full Text] [Related]
15. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in head and neck cancer.
Haddad RI; Shin DM
N Engl J Med; 2008 Sep; 359(11):1143-54. PubMed ID: 18784104
[No Abstract] [Full Text] [Related]
18. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).
Huang SM; Li J; Armstrong EA; Harari PM
Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-MarĂa IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
20. Current status of experimental therapeutics for head and neck cancer.
Lee J; Moon C
Exp Biol Med (Maywood); 2011 Apr; 236(4):375-89. PubMed ID: 21427235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]